246 related articles for article (PubMed ID: 19467938)
1. Cost-effectiveness of early colonoscopy surveillance after cancer resection.
Hassan C; Pickhardt PJ; Zullo A; Di Giulio E; Laghi A; Kim DH; Iafrate F
Dig Liver Dis; 2009 Dec; 41(12):881-5. PubMed ID: 19467938
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of colonoscopy, based on the appropriateness of an indication.
Hassan C; Di Giulio E; Pickhardt PJ; Zullo A; Laghi A; Kim DH; Iafrate F; Morini S
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1231-6. PubMed ID: 18995214
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of early one-year colonoscopy surveillance after polypectomy.
Hassan C; Pickhardt PJ; Di Giulio E; Kim DH; Zullo A; Morini S
Dis Colon Rectum; 2009 May; 52(5):964-71; discussion 971. PubMed ID: 19502863
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia.
Hassan C; Zullo A; Di Giulio E; Annibale B; Lahner E; De Francesco V; Ierardi E
Helicobacter; 2010 Jun; 15(3):221-6. PubMed ID: 20557364
[TBL] [Abstract][Full Text] [Related]
5. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.
Hassan C; Rex DK; Cooper GS; Benamouzig R
Endoscopy; 2012 May; 44(5):456-64. PubMed ID: 22531982
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
Hassan C; Zullo A; Winn S; Morini S
Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
8. Surveillance colonoscopy is cost-effective for patients with adenomas who are at high risk of colorectal cancer.
Saini SD; Schoenfeld P; Vijan S
Gastroenterology; 2010 Jun; 138(7):2292-9, 2299.e1. PubMed ID: 20226186
[TBL] [Abstract][Full Text] [Related]
9. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
DuPont AW; Arguedas MR; Wilcox CM
Aliment Pharmacol Ther; 2007 Aug; 26(3):431-41. PubMed ID: 17635378
[TBL] [Abstract][Full Text] [Related]
10. Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience.
Matarese VG; Feo CV; Pezzoli A; Trevisani L; Brancaleoni M; Gullini S
Eur J Cancer Prev; 2007 Aug; 16(4):292-7. PubMed ID: 17554201
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.
Heitman SJ; Manns BJ; Hilsden RJ; Fong A; Dean S; Romagnuolo J
CMAJ; 2005 Oct; 173(8):877-81. PubMed ID: 16217110
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of upper gastrointestinal endoscopy according to the appropriateness of the indication.
Di Giulio E; Hassan C; Pickhardt PJ; Zullo A; Laghi A; Kim DH; Iafrate F
Scand J Gastroenterol; 2009; 44(4):491-8. PubMed ID: 19031302
[TBL] [Abstract][Full Text] [Related]
13. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
14. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.
van Gils P; van den Berg M; van Kranen H; de Wit AG
Eur J Cancer; 2009 Jun; 45(9):1554-9. PubMed ID: 19261464
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer.
Rex DK; Kahi CJ; Levin B; Smith RA; Bond JH; Brooks D; Burt RW; Byers T; Fletcher RH; Hyman N; Johnson D; Kirk L; Lieberman DA; Levin TR; O'Brien MJ; Simmang C; Thorson AG; Winawer SJ; ;
Gastroenterology; 2006 May; 130(6):1865-71. PubMed ID: 16697749
[TBL] [Abstract][Full Text] [Related]
16. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs.
Ramsey SD; Wilschut J; Boer R; van Ballegooijen M
Am J Gastroenterol; 2010 Aug; 105(8):1861-9. PubMed ID: 20461066
[TBL] [Abstract][Full Text] [Related]
17. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
18. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients.
Rulyak SJ; Lieberman DA; Wagner EH; Mandelson MT
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):470-6; quiz 407. PubMed ID: 17270502
[TBL] [Abstract][Full Text] [Related]
19. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening.
Shankaran V; McKoy JM; Dandade N; Nonzee N; Tigue CA; Bennett CL; Denberg TD
J Clin Oncol; 2007 Nov; 25(33):5248-53. PubMed ID: 18024871
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
